Protective effect of L-carnitine nanoparticles Vs carnitine on lead acetate-induced toxicity in male rats

Table 1. Effects of different treatments on liver enzyme activity in male rats.

Groups	parameters (Mean ± S.D.)
Groups	AST (U/L)	ALT (U/L)	ALP (U/L)
Control	146.8 ± 7.66^c	72.5 ± 3.88^c	81.4 ± 3.90^d
Lead acetate (U/L)	203.5 ± 8.47^a	127.0 ± 6.43^a	130.5 ± 5.72^a
Lead + L.Carnitin (U/L)	175.8± 10.41^b	101.3 ± 5.25^b	110.7 ± 8.73^b
Lead + Nano L.Carnitin (U/L)	166.0 ± 6.69^b	99.2 ± 3.67^b	93.8 ± 7.5^c
L.Carnitin (U/L)	148.9 ± 6.40^c	66.6 ± 5.16^dc	82.5 ± 6.29^d
L.Carnitin Nano (U/L)	143.0 ± 8.92^c	62.4 ± 5.82^d	70.4 ± 5.71^e
LSD	7.36	4.60	5.82

*The different small letters do not show significant differences at (P<0.05). a, b, c, d, and e letters refer to significance between the groups according to the Duncan test.